An empiric antibiotic protocol using risk stratification improves antibiotic selection and timing in critically ill children

Ann Am Thorac Soc. 2014 Dec;11(10):1569-75. doi: 10.1513/AnnalsATS.201408-389OC.

Abstract

Rationale: Timely and appropriate empiric antibiotics can improve outcomes in critically ill patients with infection. Evidence and guidelines to guide empiric antibiotic decisions are lacking for critically ill children.

Objectives: To evaluate the impact of an empiric antibiotic protocol on appropriateness of initial antibiotics and time to appropriate antibiotics in critically ill children with suspected infection.

Methods: A computer order entry-based, pediatric intensive care unit-specific, empiric antibiotic protocol including risk stratification for healthcare-associated infections was implemented in a tertiary pediatric intensive care unit. Antibiotic and culture data were evaluated for a total of 556 infectious episodes in 491 patients from 2004 (preprotocol, n = 252) and 2007 (protocol, n = 304) with suspected infection. Antibiotics appropriateness based on risk factors and culture results was assessed, as was time from initial culture to appropriate antibiotics.

Measurements and main results: Patients treated using the protocols were more likely to receive appropriate empiric antibiotics based on risk factors (76 vs. 15%; P < 0.0001) and culture results (89 vs. 64%; P < 0.0001). Patients treated after protocol implementation had a shorter time to appropriate antibiotics (median, 5.9 vs. 9.6 h; P < 0.0001), particularly in those who grew healthcare-associated pathogens (5.8 vs. 24 h; P = 0.0001). No significant baseline characteristic differences were seen.

Conclusions: An empiric antibiotic protocol in the pediatric intensive care unit incorporating risk stratification for healthcare-associated infections resulted in increased appropriateness of empiric antibiotics and in decreased time to appropriate antibiotics in critically ill children with infection.

Keywords: antibiotic resistance; pediatric intensive care unit; treatment protocol.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Critical Illness / mortality
  • Critical Illness / therapy*
  • Drug Resistance, Microbial*
  • Empirical Research*
  • Female
  • Follow-Up Studies
  • Humans
  • Infections / drug therapy*
  • Infections / mortality
  • Intensive Care Units, Pediatric
  • Male
  • Ohio / epidemiology
  • Retrospective Studies
  • Risk Assessment / methods*
  • Survival Rate / trends
  • Time Factors

Substances

  • Anti-Bacterial Agents